BioCentury
ARTICLE | Financial News

Medigene raises €32.3M in private placement

May 25, 2018 6:19 PM UTC

Medigene AG (Xetra:MDG1) raised €32.3M ($37.9M) on May 24 through the sale of 2.2 million shares at €14.50 in an oversubscribed private placement to institutional investors underwritten by Guggenheim Securities, Baader Bank and Bryan Garnier.

Medigene and bluebird bio Inc. (NASDAQ:BLUE) announced on May 14 the expansion of their 2016 deal to research and develop T cell receptor immunotherapies to treat cancer (see BioCentury, May 18)...

BCIQ Company Profiles

Medigene AG